The URMC has a long and distinguished track record in HIV/AIDS research, dating back to the earliest days of the epidemic. UR was also a founding member of both the HIV Vaccine Trials Network (HVTN) and the AIDS Clinical Trials Group (ACTG), or their preceding organizations, and has a proud tradition of vaccine research – including the invention of ground-breaking technologies that were commercially licensed to develop the human papillomavirus (HPV) vaccines that are now used worldwide to protect against cervical and anogenital cancers.
The CFAR serves as an anchor for HIV/AIDS researchers at the URMC and a catalyst for innovation by providing leadership and infrastructure to create new interdisciplinary collaborations which result in high-impact research. View recent publications.
Researcher Awarded $2M to Train Patients, Use iPods, for Decision-Making »
December 18, 2013
URMC Research Groups, Community Observe 25th Annual World AIDS Day »
November 27, 2013
URMC Named a Leader in LGBT Healthcare Equality »
July 16, 2013
UR Named Center for AIDS Research by the National Institutes of Health »
May 09, 2013
As Our Understanding of HIV Evolves, Grant Helps Providers Keep Pace »
February 19, 2013
In honor of World AIDS Day the CFAR hosted a scientific symposium featuring talks from prestigious experts in the AIDS community and research posters from students and post doctoral associates training at the UR.
Congratulations to this year's poster award recipients!
*David Griffith, Departments of Internal Medicine/Pediatrics and Emergency Medicine
*Meera Singh, Department of Microbiology and Immunology
*John DiMaio, Department of Chemistry
*Katherine Thomas, Department of Psychiatry
*Christopher Nishimura, Department of Microbiology and Immunology